SEC Info - Hi Tech Pharmacal Co Inc - ‘10-K’ for 4/30/10

SEC Info℠

Home

Help

Please Sign In

Hi Tech Pharmacal Co Inc – ‘10-K’ for 4/30/10 – EX-32.1

On: Wednesday, 7/14/10, at 3:51pm ET · For: 4/30/10 · Accession #: 1193125-10-158797 · File #: 0-20424

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 7/14/10  Hi Tech Pharmacal Co Inc          10-K        4/30/10    6:1.3M                                   RR Donnelley/FA

Annual Report — Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        For Fiscal Year Ended April 30, 2010                HTML    989K 
 2: EX-21.1     Subsidiaries of the Registrant                      HTML      5K 
 3: EX-23.1     Consent of Eisner LLP                               HTML      7K 
 4: EX-31.1     Certification Pursuant to Section 302 of the        HTML     14K 
                          Sarbanes-Oxley Act of 2002                             
 5: EX-31.2     Certification Pursuant to Section 302 of the        HTML     14K 
                          Sarbanes-Oxley Act of 2002                             
 6: EX-32.1     Certification of Chief Executive Officer and Chief  HTML      8K 
                          Financial Officer

EX-32.1 — Certification of Chief Executive Officer and Chief Financial Officer

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

EXHIBIT 32.1

HI-TECH PHARMACAL CO., INC.

CERTIFICATION PURSUANT TO 18 U. S. C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF

THE

SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officers of Hi-Tech Pharmacal Co., Inc. (the “Company”), hereby certify to such officers’ knowledge, that the Company’s Annual Report on Form 10-K for the year ended April 30, 2010 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: July 14, 2010

/s/ David Seltzer

David Seltzer,

Chief Executive Officer

/s/ William Peters

William Peters,

Chief Financial Officer

This certification is being furnished solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Dates Referenced Herein

This ‘10-K’ Filing	Date	Other Filings

Filed on:	7/14/10	None on these Dates
For Period End:	4/30/10
		List all Filings

↑Top

Filing Submission 0001193125-10-158797 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)